Webinar | January 14, 2022

Scalable Manufacturing Of MSC-Derived EVs

Source: RoosterBio

Extracellular Vesicles (EVs) are a growing segment of Regenerative Medicine and are particularly attractive as a therapeutic model, utilizing a non-viable biologically active agent. In her presentation at ISEV, Taby Ahsan discusses considerations for the manufacturing of EVs derived from mesenchymal stem/stromal cells, including the tissue source, the cell state, and process parameters. She also discusses the importance of evaluating EV productivity in manufacturing processes, highlighting limitations and advantages of 2D and 3D bioreactor production.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene